| 52.52 Delayed Data As of Oct 18 |  -0.16 / -0.30%Today’s Change | 41.59 Today|||52-Week Range 53.55 | +14.00% Year-to-Date |
| Previous close | 52.68 |
| Today’s open | 52.63 |
| Day’s range | 52.17 - 52.65 |
| Volume | 780,985 |
| Average volume (3 months) | 1,449,147 |
| Market cap | $94.9B |
| Earnings growth (last year) | +8.07% |
| Earnings growth (this year) | -0.77% |
| Earnings growth (next 5 years) | +10.02% |
| Revenue growth (last year) | +4.51% |
| P/E ratio | 22.4 |
| Price/Sales | 6.31 |
| Price/Book | 15.83 |
| Today’s change | Today’s % change | |
|---|---|---|
| BMYBristol-Myers Squibb | +0.61 | +1.16% |
| LLYEli Lilly and Co | +0.18 | +0.17% |
| GSKGlaxoSmithKline | +0.06 | +0.14% |
| ABBVAbbVie | +1.32 | +1.76% |
| Next reporting date | November 1, 2019 |
| EPS forecast (this quarter) | $0.56 |
| Annual revenue (last year) | $17.7B |
| Annual profit (last year) | $6.1B |
| Net profit margin | 34.54% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bagsværd, Capital Region |
